Inspira has completed the first real-world procedure of its extracorporeal blood circulation device at New York’s Westchester ...

First Clinical Use of INSPIRA ART100 System Successfully Completes Full Treatment Cycle, Validating the Technology’s Performance in a Real-World Clinical Environment and Garnering Overwhelmingly ...

Give them a break, writes our Modern Guru. They were exhausted, possibly inebriated – and thankfully, not relying on ...

OKLAHOMA CITY – Clinical trial results published March 29 in the Journal of the American Medical Association indicate a potential shift in managing ...

Clinical trial results published March 29 in the Journal of the American Medical Association indicate a potential shift in managing bleeding complications after major open-heart surgery.

The prothrombin complex concentrate costs more than plasma, but may pay dividends by way of fewer adverse events.

Key points Heart surgery requiring the heart-lung machine (cardiopulmonary bypass) saves lives but can cause brain and kidney problems in many ...

Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the ...

Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. It is used to prevent formation of blood clots caused by certain ...

Inspira Technologies (IINN) has successfully completed the installation, training program and operational readiness for its INSPIRA ART100 ...

Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it has successfully completed ...